covid 19 News and Research

RSS

SARS-CoV-2 develops partial resistance to the antiviral drug remdesivir in cell culture

The virus that causes COVID-19 can develop partial resistance to the antiviral drug remdesivir during infection of cultured cells in the laboratory by more than one mechanism.

5 May 2022

Results indicate that Omicron infection induces low levels of neutralizing antibodies in immunocompetent individuals

Researchers assessed the induction of variant-specific neutralizing antibodies against the SARS-CoV-2 spike and nucleocapsid proteins of several SARS-CoV-2 strains.

5 May 2022

£1.5 million funding to support new project using an at-home test to detect HPV

A new project using an at-home test to detect Human papillomavirus (HPV) is being trialed in Hull and Manchester, thanks to £1.5 million funding from the charity Yorkshire Cancer Research.

5 May 2022

The impact of COVID-19 on digital health adoption

A new study analyzed the impact that coronavirus disease 2019 has had on the adoption of digital health.

5 May 2022

Study assesses the efficacy and safety of lithium treatment in patients infected with severe SARS-CoV-2

Researchers assessed the efficacy and safety of using lithium for coronavirus disease 2019 (COVID-19) treatment.

5 May 2022

Study identifies two new Omicron lineages associated with a resurgence in infections in South Africa

Researchers assessed the emergence and evolution of SARS-CoV-2 Omicron variant in South Africa.

5 May 2022

Mologic and Alamar Biosciences collaborate to develop a next generation COVID-19 antigen test

...

5 May 2022

Potential indirect and direct effects of SARS-CoV-2 on pancreatic islets in patients who became hyperglycemic after COVID-19

In a recent study published in Diabetes, researchers assessed the direct and indirect effects of SARS-CoV-2 on human pancreatic islets.

5 May 2022

Free SARS-CoV-2 spike protein fragments may trigger platelet activation and clot formation in COVID-19

In a recent study under review in the Nature Portfolio journal and currently available on the Research Square* preprint server, researchers investigated the presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (SP) in the thrombi (or blood clots).

5 May 2022

Efficacy and safety of a 3rd dose of mRNA-1273 SARS-CoV-2 vaccine

In a recent study posted to the Research Square* preprint server, researchers tested the safety and immunogenicity of a third dose of coronavirus disease 2019 (COVID-19) prototype messenger ribonucleic acid (mRNA)-1273 versus a variant vaccine and a bivalent vaccine formulation.

5 May 2022

Relevance of stem-loop 2 motif in SARS-CoV-2 and astroviruses

A recent paper posted to the bioRxiv* preprint server demonstrated that the stem-loop 2 motif (s2m) was substantial for astroviruses but unnecessary for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

5 May 2022

SARS-CoV-2 Omicron BA.2.12.1, BA.4 and BA.5 subvariants are superior to their predecessors

A recent study posted to the bioRxiv* preprint server demonstrated that the latest severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron sublineages evade immunity imparted by the prior subvariants.

5 May 2022

Oral Nirmatrelvir's effects on long COVID symptoms

In a recent study posted to the Research Square* preprint server, researchers at the University of California, San Francisco, examined the cases of three individuals who received nirmatrelvir/ritonavir antiviral therapy at different stages following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

4 May 2022

Study offers provable standards for SARS-CoV-2 UVC disinfection

When the COVID-19 pandemic emerged in early 2020, ultraviolet radiation became one of the go-to methods for preventing the spread of the SARS-CoV-2 virus, along with facemasks, hand sanitizer and social distancing.

4 May 2022

Researchers identify factors that influence people's vaccine preferences

A study involving hypothetical COVID-19 vaccines suggests that vaccine effectiveness and risk of side effects significantly influence people's preferences for one vaccine over another, and that differences between vaccines may matter less to those who are vaccine hesitant.

4 May 2022

covid 19 News and Research

SARS-CoV-2 develops partial resistance to the antiviral drug remdesivir in cell culture

Results indicate that Omicron infection induces low levels of neutralizing antibodies in immunocompetent individuals

£1.5 million funding to support new project using an at-home test to detect HPV

The impact of COVID-19 on digital health adoption

Study assesses the efficacy and safety of lithium treatment in patients infected with severe SARS-CoV-2

Study identifies two new Omicron lineages associated with a resurgence in infections in South Africa

Mologic and Alamar Biosciences collaborate to develop a next generation COVID-19 antigen test

Potential indirect and direct effects of SARS-CoV-2 on pancreatic islets in patients who became hyperglycemic after COVID-19

Free SARS-CoV-2 spike protein fragments may trigger platelet activation and clot formation in COVID-19

Efficacy and safety of a 3rd dose of mRNA-1273 SARS-CoV-2 vaccine

Relevance of stem-loop 2 motif in SARS-CoV-2 and astroviruses

SARS-CoV-2 Omicron BA.2.12.1, BA.4 and BA.5 subvariants are superior to their predecessors

Oral Nirmatrelvir's effects on long COVID symptoms

Study offers provable standards for SARS-CoV-2 UVC disinfection

Researchers identify factors that influence people's vaccine preferences

Past cancer history not linked with increased mortality or hospitalization due to COVID-19

Study explores long COVID in adults

Bacteria-mediated oral delivery of viral replicon-based mRNA vaccines

Exploring definitions related to COVID-19 infection and deaths

The war against COVID-19: reinfection, vaccines, and herd immunity

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News